Un camino hacia el futuro más esperanzador en los pacientes con linfangioleiomiomatosis: sirolimus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Un camino hacia el futuro más esperanzador en los pacientes con linfangioleiomiomatosis: sirolimus

Published:2020-10 Issue:4 Volume:2 Page:301-303
ISSN:2659-6636
Container-title:Open Respiratory Archives
language:es
Short-container-title:Open Respiratory Archives

Author:

Gámiz-Molina Ana Belén,Gámez-Baeza Pablo,Cabrero-Rodríguez Celia,Rodríguez Morillas Diego,Casas-Maldonado Francisco

Publisher

Elsevier BV

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference12 articles.

1. Linfangioleiomiomatosis: novedades terapéuticas;Casanova;Arch Bronconeumol,2011

2. Sirolimus therapy for patients with lymphangioleiomyomatosis leads to loss of chylous ascites and circulating LAM cells;Harari;Chest,2016

3. Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis;Hu;Orphanet J Rare Dis,2019

4. Sirolimus decreases circulating lymphangioleiomyomatosis cells in patients with lymphangioleiomyomatosis;Cai;Chest,2014

5. Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis;Yao;Am J Respir Crit Care Med,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP